Repare Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RPTX for the last quarter is 13.05 M USD, and it's 504.31% higher compared to the previous quarter. The net income of Q4 23 is -28.03 M USD.